Y.D. More Investments Ltd Sells 1,796 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Y.D. More Investments Ltd cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 57.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,312 shares of the healthcare conglomerate’s stock after selling 1,796 shares during the period. Y.D. More Investments Ltd’s holdings in UnitedHealth Group were worth $663,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB lifted its position in shares of UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the last quarter. Czech National Bank increased its holdings in UnitedHealth Group by 7.3% in the third quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock valued at $109,984,000 after purchasing an additional 12,721 shares during the period. Hudson Value Partners LLC increased its position in shares of UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after buying an additional 82 shares during the period. Versant Capital Management Inc boosted its position in shares of UnitedHealth Group by 17.8% during the 3rd quarter. Versant Capital Management Inc now owns 1,011 shares of the healthcare conglomerate’s stock valued at $591,000 after purchasing an additional 153 shares in the last quarter. Finally, Ignite Planners LLC increased its stake in UnitedHealth Group by 11.2% during the 3rd quarter. Ignite Planners LLC now owns 1,353 shares of the healthcare conglomerate’s stock valued at $791,000 after purchasing an additional 136 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on UNH shares. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Down 0.6 %

NYSE:UNH opened at $545.08 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company’s 50-day simple moving average is $535.03 and its 200-day simple moving average is $565.09. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $501.63 billion, a P/E ratio of 35.17, a P/E/G ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company posted $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.